Contact Information

Call us at: (614) 722-6224

Email Mykyta Artomov, PhD

Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)

Learn more about Mykyta Artomov

Biography

Mykyta Artomov, PhD, is an Assistant Professor at the Institute for Genomic Medicine (IGM), where he works on developing the concept of systems genetics – the integration of multiple data sources (e.g. DNA sequencing, gene expression data) in statistical frameworks that aid interpretability of experimental outcomes and novel biological hypothesis generation. His primary research focus is on developing methods for genome and exome sequencing data anaylsis and sharing, building statistical models for health outcomes using clinical and genetic data. Applied aspects of Dr. Artomov’s work include understanding inherited susceptibilities for complex diseases – identification of disease risk genes, pathways and affected cell types. In integration with electronic healthcare records such an approach is used by Dr. Artomov to build predictive models for health outcomes. In his postdoctoral work Dr. Artomov built tools for understanding of the biology of autistic spectrum disorder and 22q11 deletion syndrome through protein-protein network analyses. Deep experience of working with large-scale sequencing data acquired throughout his career led to a development of the algorithm for case-control association studies that do not require sharing of the individual-level data and creation of the public repository of ~40,000 exome controls.

Awards, Honors & Organizations

Travel Award for Graduate Student’s Research Projects, Center for Genomic Medicine, Massachusetts General Hospital, 2017 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2017 Distinction in Teaching, Harvard University, 2016 Distinction in Teaching, Harvard University, 2015 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2015

Research

Publications

                  Nehme R, Pietiläinen O, Artomov M, Tegtmeyer M, Valakh V, Lehtonen L, Bell C, Singh T, Trehan A, Sherwood J, Manning D, Peirent E, Malik R, Guss EJ, Hawes D, Beccard A, Bara AM, Hazelbaker DZ, Zuccaro E, Genovese G, Loboda AA, Neumann A, Lilliehook C, Kuismin O, Hamalainen E, Kurki M, Hultman CM, Kähler AK, Paulo JA, Ganna A, Madison J, Cohen B, McPhie D, Adolfsson R, Perlis R, Dolmetsch R, Farhi S, McCarroll S, Hyman S, Neale B, Barrett LE, Harper W, Palotie A, Daly M, Eggan K. The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia. Nat Commun. 2022 Jun 27; 13: 3690.

                


                  Kolosov N, Daly MJ, Artomov M. Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning. Eur J Hum Genet. 2021 Oct; 29: 1527-1535.

                


                  Shchukina I, Bagaitkar J, Shpynov O, Loginicheva E, Porter S, Mogilenko DA, Wolin E, Collins P, Demidov G, Artomov M, Zaitsev K, Sidorov S, Camell C, Bambouskova M, Arthur L, Swain A, Panteleeva A, Dievskii A, Kurbatsky E, Tsurinov P, Chernyatchik R, Dixit VD, Jovanovic M, Stewart SA, Daly MJ, Dmitriev S, Oltz EM, Artyomov MN. Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome. Nat Aging. 2021 Jan; 1: 124-141.

                


                  Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, Peng M, Collins R, Grove J, Klei L, Stevens C, Reichert J, Mulhern MS, Artomov M, Gerges S, Sheppard B, Xu X, Bhaduri A, Norman U, Brand H, Schwartz G, Nguyen R, Guerrero EE, Dias C, Autism Sequencing Consortium., iPSYCH-Broad Consortium., Betancur C, Cook EH, Gallagher L, Gill M, Sutcliffe JS, Thurm A, Zwick ME, Børglum AD, State MW, Cicek AE, Talkowski ME, Cutler DJ, Devlin B, Sanders SJ, Roeder K, Daly MJ, Buxbaum JD. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020 Feb 6; 180: 568-584.e23.

                


                  Shaughnessy M, Njauw CN, Artomov M, Tsao H. Classifying Melanoma by TERT Promoter Mutational Status. J Invest Dermatol. 2020 Feb; 140: 390-394.e1.

                


                  Heyne HO, Artomov M, Battke F, Bianchini C, Smith DR, Liebmann N, Tadigotla V, Stanley CM, Lal D, Rehm H, Lerche H, Daly MJ, Helbig I, Biskup S, Weber YG, Lemke JR. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med. 2019 Nov; 21: 2496-2503.

                


                  Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. J Natl Cancer Inst. 2017 Dec 1; 109: 

                


                  Artomov M, Rivas MA, Genovese G, Daly MJ. Mosaic mutations in blood DNA sequence are associated with solid tumor cancers. NPJ Genom Med. 2017; 2: 22.

View More Publications

Education

Post Doctoral

Massachusetts General Hospital

Date Completed: 03/31/2021

Graduate School

Harvard University

Date Completed: 05/25/2017

Professional Experience

2012 - Present Broad Institute, Affiliated Researcher2021 - 2022 Massachusetts General Hospital, Instructor in Investigation2021 - 2022 Harvard Medical School, Instructor in Medicine

Contact Information

Institute for Genomic Medicine

Call us at: (614) 722-6224

Email Mykyta Artomov

                    575 Children's CrossroadColumbus, OH 43215 (map)

Connect with Mykyta Artomov

Connect on ResearchGate

Contact Information

Call us at: (614) 722-6224

Email Mykyta Artomov, PhD

Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)

Learn more about Mykyta Artomov

Biography

Mykyta Artomov, PhD, is an Assistant Professor at the Institute for Genomic Medicine (IGM), where he works on developing the concept of systems genetics – the integration of multiple data sources (e.g. DNA sequencing, gene expression data) in statistical frameworks that aid interpretability of experimental outcomes and novel biological hypothesis generation. His primary research focus is on developing methods for genome and exome sequencing data anaylsis and sharing, building statistical models for health outcomes using clinical and genetic data. Applied aspects of Dr. Artomov’s work include understanding inherited susceptibilities for complex diseases – identification of disease risk genes, pathways and affected cell types. In integration with electronic healthcare records such an approach is used by Dr. Artomov to build predictive models for health outcomes. In his postdoctoral work Dr. Artomov built tools for understanding of the biology of autistic spectrum disorder and 22q11 deletion syndrome through protein-protein network analyses. Deep experience of working with large-scale sequencing data acquired throughout his career led to a development of the algorithm for case-control association studies that do not require sharing of the individual-level data and creation of the public repository of ~40,000 exome controls.

Awards, Honors & Organizations

Travel Award for Graduate Student’s Research Projects, Center for Genomic Medicine, Massachusetts General Hospital, 2017 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2017 Distinction in Teaching, Harvard University, 2016 Distinction in Teaching, Harvard University, 2015 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2015

Research

Publications

                  Nehme R, Pietiläinen O, Artomov M, Tegtmeyer M, Valakh V, Lehtonen L, Bell C, Singh T, Trehan A, Sherwood J, Manning D, Peirent E, Malik R, Guss EJ, Hawes D, Beccard A, Bara AM, Hazelbaker DZ, Zuccaro E, Genovese G, Loboda AA, Neumann A, Lilliehook C, Kuismin O, Hamalainen E, Kurki M, Hultman CM, Kähler AK, Paulo JA, Ganna A, Madison J, Cohen B, McPhie D, Adolfsson R, Perlis R, Dolmetsch R, Farhi S, McCarroll S, Hyman S, Neale B, Barrett LE, Harper W, Palotie A, Daly M, Eggan K. The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia. Nat Commun. 2022 Jun 27; 13: 3690.

                


                  Kolosov N, Daly MJ, Artomov M. Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning. Eur J Hum Genet. 2021 Oct; 29: 1527-1535.

                


                  Shchukina I, Bagaitkar J, Shpynov O, Loginicheva E, Porter S, Mogilenko DA, Wolin E, Collins P, Demidov G, Artomov M, Zaitsev K, Sidorov S, Camell C, Bambouskova M, Arthur L, Swain A, Panteleeva A, Dievskii A, Kurbatsky E, Tsurinov P, Chernyatchik R, Dixit VD, Jovanovic M, Stewart SA, Daly MJ, Dmitriev S, Oltz EM, Artyomov MN. Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome. Nat Aging. 2021 Jan; 1: 124-141.

                


                  Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, Peng M, Collins R, Grove J, Klei L, Stevens C, Reichert J, Mulhern MS, Artomov M, Gerges S, Sheppard B, Xu X, Bhaduri A, Norman U, Brand H, Schwartz G, Nguyen R, Guerrero EE, Dias C, Autism Sequencing Consortium., iPSYCH-Broad Consortium., Betancur C, Cook EH, Gallagher L, Gill M, Sutcliffe JS, Thurm A, Zwick ME, Børglum AD, State MW, Cicek AE, Talkowski ME, Cutler DJ, Devlin B, Sanders SJ, Roeder K, Daly MJ, Buxbaum JD. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020 Feb 6; 180: 568-584.e23.

                


                  Shaughnessy M, Njauw CN, Artomov M, Tsao H. Classifying Melanoma by TERT Promoter Mutational Status. J Invest Dermatol. 2020 Feb; 140: 390-394.e1.

                


                  Heyne HO, Artomov M, Battke F, Bianchini C, Smith DR, Liebmann N, Tadigotla V, Stanley CM, Lal D, Rehm H, Lerche H, Daly MJ, Helbig I, Biskup S, Weber YG, Lemke JR. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med. 2019 Nov; 21: 2496-2503.

                


                  Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. J Natl Cancer Inst. 2017 Dec 1; 109: 

                


                  Artomov M, Rivas MA, Genovese G, Daly MJ. Mosaic mutations in blood DNA sequence are associated with solid tumor cancers. NPJ Genom Med. 2017; 2: 22.

View More Publications

Education

Post Doctoral

Massachusetts General Hospital

Date Completed: 03/31/2021

Graduate School

Harvard University

Date Completed: 05/25/2017

Professional Experience

2012 - Present Broad Institute, Affiliated Researcher2021 - 2022 Massachusetts General Hospital, Instructor in Investigation2021 - 2022 Harvard Medical School, Instructor in Medicine

Contact Information

Institute for Genomic Medicine

Call us at: (614) 722-6224

Email Mykyta Artomov

                    575 Children's CrossroadColumbus, OH 43215 (map)

Connect with Mykyta Artomov

Connect on ResearchGate

Contact Information

Call us at: (614) 722-6224

Email Mykyta Artomov, PhD

Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)

Learn more about Mykyta Artomov

Contact Information

  • Call us at:
  • (614) 722-6224
  • Email Mykyta Artomov, PhD
  • Institute for Genomic Medicine575 Children’s CrossroadColumbus, OH 43215 (map)

Learn more about Mykyta Artomov

Biography

Mykyta Artomov, PhD, is an Assistant Professor at the Institute for Genomic Medicine (IGM), where he works on developing the concept of systems genetics – the integration of multiple data sources (e.g. DNA sequencing, gene expression data) in statistical frameworks that aid interpretability of experimental outcomes and novel biological hypothesis generation. His primary research focus is on developing methods for genome and exome sequencing data anaylsis and sharing, building statistical models for health outcomes using clinical and genetic data. Applied aspects of Dr. Artomov’s work include understanding inherited susceptibilities for complex diseases – identification of disease risk genes, pathways and affected cell types. In integration with electronic healthcare records such an approach is used by Dr. Artomov to build predictive models for health outcomes. In his postdoctoral work Dr. Artomov built tools for understanding of the biology of autistic spectrum disorder and 22q11 deletion syndrome through protein-protein network analyses. Deep experience of working with large-scale sequencing data acquired throughout his career led to a development of the algorithm for case-control association studies that do not require sharing of the individual-level data and creation of the public repository of ~40,000 exome controls.

Biography

Mykyta Artomov, PhD, is an Assistant Professor at the Institute for Genomic Medicine (IGM), where he works on developing the concept of systems genetics – the integration of multiple data sources (e.g. DNA sequencing, gene expression data) in statistical frameworks that aid interpretability of experimental outcomes and novel biological hypothesis generation. His primary research focus is on developing methods for genome and exome sequencing data anaylsis and sharing, building statistical models for health outcomes using clinical and genetic data. Applied aspects of Dr. Artomov’s work include understanding inherited susceptibilities for complex diseases – identification of disease risk genes, pathways and affected cell types. In integration with electronic healthcare records such an approach is used by Dr. Artomov to build predictive models for health outcomes. In his postdoctoral work Dr. Artomov built tools for understanding of the biology of autistic spectrum disorder and 22q11 deletion syndrome through protein-protein network analyses. Deep experience of working with large-scale sequencing data acquired throughout his career led to a development of the algorithm for case-control association studies that do not require sharing of the individual-level data and creation of the public repository of ~40,000 exome controls.

Biography

Mykyta Artomov, PhD, is an Assistant Professor at the Institute for Genomic Medicine (IGM), where he works on developing the concept of systems genetics – the integration of multiple data sources (e.g. DNA sequencing, gene expression data) in statistical frameworks that aid interpretability of experimental outcomes and novel biological hypothesis generation. His primary research focus is on developing methods for genome and exome sequencing data anaylsis and sharing, building statistical models for health outcomes using clinical and genetic data. Applied aspects of Dr. Artomov’s work include understanding inherited susceptibilities for complex diseases – identification of disease risk genes, pathways and affected cell types. In integration with electronic healthcare records such an approach is used by Dr. Artomov to build predictive models for health outcomes. In his postdoctoral work Dr. Artomov built tools for understanding of the biology of autistic spectrum disorder and 22q11 deletion syndrome through protein-protein network analyses. Deep experience of working with large-scale sequencing data acquired throughout his career led to a development of the algorithm for case-control association studies that do not require sharing of the individual-level data and creation of the public repository of ~40,000 exome controls.

Mykyta Artomov, PhD, is an Assistant Professor at the Institute for Genomic Medicine (IGM), where he works on developing the concept of systems genetics – the integration of multiple data sources (e.g. DNA sequencing, gene expression data) in statistical frameworks that aid interpretability of experimental outcomes and novel biological hypothesis generation. His primary research focus is on developing methods for genome and exome sequencing data anaylsis and sharing, building statistical models for health outcomes using clinical and genetic data. Applied aspects of Dr. Artomov’s work include understanding inherited susceptibilities for complex diseases – identification of disease risk genes, pathways and affected cell types. In integration with electronic healthcare records such an approach is used by Dr. Artomov to build predictive models for health outcomes. In his postdoctoral work Dr. Artomov built tools for understanding of the biology of autistic spectrum disorder and 22q11 deletion syndrome through protein-protein network analyses. Deep experience of working with large-scale sequencing data acquired throughout his career led to a development of the algorithm for case-control association studies that do not require sharing of the individual-level data and creation of the public repository of ~40,000 exome controls.

Mykyta Artomov, PhD, is an Assistant Professor at the Institute for Genomic Medicine (IGM), where he works on developing the concept of systems genetics – the integration of multiple data sources (e.g. DNA sequencing, gene expression data) in statistical frameworks that aid interpretability of experimental outcomes and novel biological hypothesis generation. His primary research focus is on developing methods for genome and exome sequencing data anaylsis and sharing, building statistical models for health outcomes using clinical and genetic data.

Applied aspects of Dr. Artomov’s work include understanding inherited susceptibilities for complex diseases – identification of disease risk genes, pathways and affected cell types. In integration with electronic healthcare records such an approach is used by Dr. Artomov to build predictive models for health outcomes.

In his postdoctoral work Dr. Artomov built tools for understanding of the biology of autistic spectrum disorder and 22q11 deletion syndrome through protein-protein network analyses. Deep experience of working with large-scale sequencing data acquired throughout his career led to a development of the algorithm for case-control association studies that do not require sharing of the individual-level data and creation of the public repository of ~40,000 exome controls.

Awards, Honors & Organizations

Travel Award for Graduate Student’s Research Projects, Center for Genomic Medicine, Massachusetts General Hospital, 2017 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2017 Distinction in Teaching, Harvard University, 2016 Distinction in Teaching, Harvard University, 2015 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2015

Awards, Honors & Organizations

Travel Award for Graduate Student’s Research Projects, Center for Genomic Medicine, Massachusetts General Hospital, 2017 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2017 Distinction in Teaching, Harvard University, 2016 Distinction in Teaching, Harvard University, 2015 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2015

Awards, Honors & Organizations

Travel Award for Graduate Student’s Research Projects, Center for Genomic Medicine, Massachusetts General Hospital, 2017 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2017 Distinction in Teaching, Harvard University, 2016 Distinction in Teaching, Harvard University, 2015 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2015

Travel Award for Graduate Student’s Research Projects, Center for Genomic Medicine, Massachusetts General Hospital, 2017 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2017 Distinction in Teaching, Harvard University, 2016 Distinction in Teaching, Harvard University, 2015 Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2015

  • Travel Award for Graduate Student’s Research Projects, Center for Genomic Medicine, Massachusetts General Hospital, 2017
  • Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2017
  • Distinction in Teaching, Harvard University, 2016
  • Distinction in Teaching, Harvard University, 2015
  • Reviewer’s Choice Poster Abstract, Annual Meeting of American Society of Human Genetics, 2015

Research

Publications

                  Nehme R, Pietiläinen O, Artomov M, Tegtmeyer M, Valakh V, Lehtonen L, Bell C, Singh T, Trehan A, Sherwood J, Manning D, Peirent E, Malik R, Guss EJ, Hawes D, Beccard A, Bara AM, Hazelbaker DZ, Zuccaro E, Genovese G, Loboda AA, Neumann A, Lilliehook C, Kuismin O, Hamalainen E, Kurki M, Hultman CM, Kähler AK, Paulo JA, Ganna A, Madison J, Cohen B, McPhie D, Adolfsson R, Perlis R, Dolmetsch R, Farhi S, McCarroll S, Hyman S, Neale B, Barrett LE, Harper W, Palotie A, Daly M, Eggan K. The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia. Nat Commun. 2022 Jun 27; 13: 3690.

                


                  Kolosov N, Daly MJ, Artomov M. Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning. Eur J Hum Genet. 2021 Oct; 29: 1527-1535.

                


                  Shchukina I, Bagaitkar J, Shpynov O, Loginicheva E, Porter S, Mogilenko DA, Wolin E, Collins P, Demidov G, Artomov M, Zaitsev K, Sidorov S, Camell C, Bambouskova M, Arthur L, Swain A, Panteleeva A, Dievskii A, Kurbatsky E, Tsurinov P, Chernyatchik R, Dixit VD, Jovanovic M, Stewart SA, Daly MJ, Dmitriev S, Oltz EM, Artyomov MN. Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome. Nat Aging. 2021 Jan; 1: 124-141.

                


                  Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, Peng M, Collins R, Grove J, Klei L, Stevens C, Reichert J, Mulhern MS, Artomov M, Gerges S, Sheppard B, Xu X, Bhaduri A, Norman U, Brand H, Schwartz G, Nguyen R, Guerrero EE, Dias C, Autism Sequencing Consortium., iPSYCH-Broad Consortium., Betancur C, Cook EH, Gallagher L, Gill M, Sutcliffe JS, Thurm A, Zwick ME, Børglum AD, State MW, Cicek AE, Talkowski ME, Cutler DJ, Devlin B, Sanders SJ, Roeder K, Daly MJ, Buxbaum JD. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020 Feb 6; 180: 568-584.e23.

                


                  Shaughnessy M, Njauw CN, Artomov M, Tsao H. Classifying Melanoma by TERT Promoter Mutational Status. J Invest Dermatol. 2020 Feb; 140: 390-394.e1.

                


                  Heyne HO, Artomov M, Battke F, Bianchini C, Smith DR, Liebmann N, Tadigotla V, Stanley CM, Lal D, Rehm H, Lerche H, Daly MJ, Helbig I, Biskup S, Weber YG, Lemke JR. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med. 2019 Nov; 21: 2496-2503.

                


                  Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. J Natl Cancer Inst. 2017 Dec 1; 109: 

                


                  Artomov M, Rivas MA, Genovese G, Daly MJ. Mosaic mutations in blood DNA sequence are associated with solid tumor cancers. NPJ Genom Med. 2017; 2: 22.

View More Publications

Research

Publications

                  Nehme R, Pietiläinen O, Artomov M, Tegtmeyer M, Valakh V, Lehtonen L, Bell C, Singh T, Trehan A, Sherwood J, Manning D, Peirent E, Malik R, Guss EJ, Hawes D, Beccard A, Bara AM, Hazelbaker DZ, Zuccaro E, Genovese G, Loboda AA, Neumann A, Lilliehook C, Kuismin O, Hamalainen E, Kurki M, Hultman CM, Kähler AK, Paulo JA, Ganna A, Madison J, Cohen B, McPhie D, Adolfsson R, Perlis R, Dolmetsch R, Farhi S, McCarroll S, Hyman S, Neale B, Barrett LE, Harper W, Palotie A, Daly M, Eggan K. The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia. Nat Commun. 2022 Jun 27; 13: 3690.

                


                  Kolosov N, Daly MJ, Artomov M. Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning. Eur J Hum Genet. 2021 Oct; 29: 1527-1535.

                


                  Shchukina I, Bagaitkar J, Shpynov O, Loginicheva E, Porter S, Mogilenko DA, Wolin E, Collins P, Demidov G, Artomov M, Zaitsev K, Sidorov S, Camell C, Bambouskova M, Arthur L, Swain A, Panteleeva A, Dievskii A, Kurbatsky E, Tsurinov P, Chernyatchik R, Dixit VD, Jovanovic M, Stewart SA, Daly MJ, Dmitriev S, Oltz EM, Artyomov MN. Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome. Nat Aging. 2021 Jan; 1: 124-141.

                


                  Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, Peng M, Collins R, Grove J, Klei L, Stevens C, Reichert J, Mulhern MS, Artomov M, Gerges S, Sheppard B, Xu X, Bhaduri A, Norman U, Brand H, Schwartz G, Nguyen R, Guerrero EE, Dias C, Autism Sequencing Consortium., iPSYCH-Broad Consortium., Betancur C, Cook EH, Gallagher L, Gill M, Sutcliffe JS, Thurm A, Zwick ME, Børglum AD, State MW, Cicek AE, Talkowski ME, Cutler DJ, Devlin B, Sanders SJ, Roeder K, Daly MJ, Buxbaum JD. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020 Feb 6; 180: 568-584.e23.

                


                  Shaughnessy M, Njauw CN, Artomov M, Tsao H. Classifying Melanoma by TERT Promoter Mutational Status. J Invest Dermatol. 2020 Feb; 140: 390-394.e1.

                


                  Heyne HO, Artomov M, Battke F, Bianchini C, Smith DR, Liebmann N, Tadigotla V, Stanley CM, Lal D, Rehm H, Lerche H, Daly MJ, Helbig I, Biskup S, Weber YG, Lemke JR. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med. 2019 Nov; 21: 2496-2503.

                


                  Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. J Natl Cancer Inst. 2017 Dec 1; 109: 

                


                  Artomov M, Rivas MA, Genovese G, Daly MJ. Mosaic mutations in blood DNA sequence are associated with solid tumor cancers. NPJ Genom Med. 2017; 2: 22.

View More Publications

Research

Publications

                  Nehme R, Pietiläinen O, Artomov M, Tegtmeyer M, Valakh V, Lehtonen L, Bell C, Singh T, Trehan A, Sherwood J, Manning D, Peirent E, Malik R, Guss EJ, Hawes D, Beccard A, Bara AM, Hazelbaker DZ, Zuccaro E, Genovese G, Loboda AA, Neumann A, Lilliehook C, Kuismin O, Hamalainen E, Kurki M, Hultman CM, Kähler AK, Paulo JA, Ganna A, Madison J, Cohen B, McPhie D, Adolfsson R, Perlis R, Dolmetsch R, Farhi S, McCarroll S, Hyman S, Neale B, Barrett LE, Harper W, Palotie A, Daly M, Eggan K. The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia. Nat Commun. 2022 Jun 27; 13: 3690.

                


                  Kolosov N, Daly MJ, Artomov M. Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning. Eur J Hum Genet. 2021 Oct; 29: 1527-1535.

                


                  Shchukina I, Bagaitkar J, Shpynov O, Loginicheva E, Porter S, Mogilenko DA, Wolin E, Collins P, Demidov G, Artomov M, Zaitsev K, Sidorov S, Camell C, Bambouskova M, Arthur L, Swain A, Panteleeva A, Dievskii A, Kurbatsky E, Tsurinov P, Chernyatchik R, Dixit VD, Jovanovic M, Stewart SA, Daly MJ, Dmitriev S, Oltz EM, Artyomov MN. Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome. Nat Aging. 2021 Jan; 1: 124-141.

                


                  Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, Peng M, Collins R, Grove J, Klei L, Stevens C, Reichert J, Mulhern MS, Artomov M, Gerges S, Sheppard B, Xu X, Bhaduri A, Norman U, Brand H, Schwartz G, Nguyen R, Guerrero EE, Dias C, Autism Sequencing Consortium., iPSYCH-Broad Consortium., Betancur C, Cook EH, Gallagher L, Gill M, Sutcliffe JS, Thurm A, Zwick ME, Børglum AD, State MW, Cicek AE, Talkowski ME, Cutler DJ, Devlin B, Sanders SJ, Roeder K, Daly MJ, Buxbaum JD. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020 Feb 6; 180: 568-584.e23.

                


                  Shaughnessy M, Njauw CN, Artomov M, Tsao H. Classifying Melanoma by TERT Promoter Mutational Status. J Invest Dermatol. 2020 Feb; 140: 390-394.e1.

                


                  Heyne HO, Artomov M, Battke F, Bianchini C, Smith DR, Liebmann N, Tadigotla V, Stanley CM, Lal D, Rehm H, Lerche H, Daly MJ, Helbig I, Biskup S, Weber YG, Lemke JR. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med. 2019 Nov; 21: 2496-2503.

                


                  Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. J Natl Cancer Inst. 2017 Dec 1; 109: 

                


                  Artomov M, Rivas MA, Genovese G, Daly MJ. Mosaic mutations in blood DNA sequence are associated with solid tumor cancers. NPJ Genom Med. 2017; 2: 22.

View More Publications

Publications

                  Nehme R, Pietiläinen O, Artomov M, Tegtmeyer M, Valakh V, Lehtonen L, Bell C, Singh T, Trehan A, Sherwood J, Manning D, Peirent E, Malik R, Guss EJ, Hawes D, Beccard A, Bara AM, Hazelbaker DZ, Zuccaro E, Genovese G, Loboda AA, Neumann A, Lilliehook C, Kuismin O, Hamalainen E, Kurki M, Hultman CM, Kähler AK, Paulo JA, Ganna A, Madison J, Cohen B, McPhie D, Adolfsson R, Perlis R, Dolmetsch R, Farhi S, McCarroll S, Hyman S, Neale B, Barrett LE, Harper W, Palotie A, Daly M, Eggan K. The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia. Nat Commun. 2022 Jun 27; 13: 3690.

                


                  Kolosov N, Daly MJ, Artomov M. Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning. Eur J Hum Genet. 2021 Oct; 29: 1527-1535.

                


                  Shchukina I, Bagaitkar J, Shpynov O, Loginicheva E, Porter S, Mogilenko DA, Wolin E, Collins P, Demidov G, Artomov M, Zaitsev K, Sidorov S, Camell C, Bambouskova M, Arthur L, Swain A, Panteleeva A, Dievskii A, Kurbatsky E, Tsurinov P, Chernyatchik R, Dixit VD, Jovanovic M, Stewart SA, Daly MJ, Dmitriev S, Oltz EM, Artyomov MN. Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome. Nat Aging. 2021 Jan; 1: 124-141.

                


                  Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, Peng M, Collins R, Grove J, Klei L, Stevens C, Reichert J, Mulhern MS, Artomov M, Gerges S, Sheppard B, Xu X, Bhaduri A, Norman U, Brand H, Schwartz G, Nguyen R, Guerrero EE, Dias C, Autism Sequencing Consortium., iPSYCH-Broad Consortium., Betancur C, Cook EH, Gallagher L, Gill M, Sutcliffe JS, Thurm A, Zwick ME, Børglum AD, State MW, Cicek AE, Talkowski ME, Cutler DJ, Devlin B, Sanders SJ, Roeder K, Daly MJ, Buxbaum JD. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020 Feb 6; 180: 568-584.e23.

                


                  Shaughnessy M, Njauw CN, Artomov M, Tsao H. Classifying Melanoma by TERT Promoter Mutational Status. J Invest Dermatol. 2020 Feb; 140: 390-394.e1.

                


                  Heyne HO, Artomov M, Battke F, Bianchini C, Smith DR, Liebmann N, Tadigotla V, Stanley CM, Lal D, Rehm H, Lerche H, Daly MJ, Helbig I, Biskup S, Weber YG, Lemke JR. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med. 2019 Nov; 21: 2496-2503.

                


                  Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. J Natl Cancer Inst. 2017 Dec 1; 109: 

                


                  Artomov M, Rivas MA, Genovese G, Daly MJ. Mosaic mutations in blood DNA sequence are associated with solid tumor cancers. NPJ Genom Med. 2017; 2: 22.

View More Publications

                  Nehme R, Pietiläinen O, Artomov M, Tegtmeyer M, Valakh V, Lehtonen L, Bell C, Singh T, Trehan A, Sherwood J, Manning D, Peirent E, Malik R, Guss EJ, Hawes D, Beccard A, Bara AM, Hazelbaker DZ, Zuccaro E, Genovese G, Loboda AA, Neumann A, Lilliehook C, Kuismin O, Hamalainen E, Kurki M, Hultman CM, Kähler AK, Paulo JA, Ganna A, Madison J, Cohen B, McPhie D, Adolfsson R, Perlis R, Dolmetsch R, Farhi S, McCarroll S, Hyman S, Neale B, Barrett LE, Harper W, Palotie A, Daly M, Eggan K. The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia. Nat Commun. 2022 Jun 27; 13: 3690.

                


                  Kolosov N, Daly MJ, Artomov M. Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning. Eur J Hum Genet. 2021 Oct; 29: 1527-1535.

                


                  Shchukina I, Bagaitkar J, Shpynov O, Loginicheva E, Porter S, Mogilenko DA, Wolin E, Collins P, Demidov G, Artomov M, Zaitsev K, Sidorov S, Camell C, Bambouskova M, Arthur L, Swain A, Panteleeva A, Dievskii A, Kurbatsky E, Tsurinov P, Chernyatchik R, Dixit VD, Jovanovic M, Stewart SA, Daly MJ, Dmitriev S, Oltz EM, Artyomov MN. Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome. Nat Aging. 2021 Jan; 1: 124-141.

                


                  Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, Peng M, Collins R, Grove J, Klei L, Stevens C, Reichert J, Mulhern MS, Artomov M, Gerges S, Sheppard B, Xu X, Bhaduri A, Norman U, Brand H, Schwartz G, Nguyen R, Guerrero EE, Dias C, Autism Sequencing Consortium., iPSYCH-Broad Consortium., Betancur C, Cook EH, Gallagher L, Gill M, Sutcliffe JS, Thurm A, Zwick ME, Børglum AD, State MW, Cicek AE, Talkowski ME, Cutler DJ, Devlin B, Sanders SJ, Roeder K, Daly MJ, Buxbaum JD. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020 Feb 6; 180: 568-584.e23.

                


                  Shaughnessy M, Njauw CN, Artomov M, Tsao H. Classifying Melanoma by TERT Promoter Mutational Status. J Invest Dermatol. 2020 Feb; 140: 390-394.e1.

                


                  Heyne HO, Artomov M, Battke F, Bianchini C, Smith DR, Liebmann N, Tadigotla V, Stanley CM, Lal D, Rehm H, Lerche H, Daly MJ, Helbig I, Biskup S, Weber YG, Lemke JR. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med. 2019 Nov; 21: 2496-2503.

                


                  Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. J Natl Cancer Inst. 2017 Dec 1; 109: 

                


                  Artomov M, Rivas MA, Genovese G, Daly MJ. Mosaic mutations in blood DNA sequence are associated with solid tumor cancers. NPJ Genom Med. 2017; 2: 22.

View More Publications

  • Nehme R, Pietiläinen O, Artomov M, Tegtmeyer M, Valakh V, Lehtonen L, Bell C, Singh T, Trehan A, Sherwood J, Manning D, Peirent E, Malik R, Guss EJ, Hawes D, Beccard A, Bara AM, Hazelbaker DZ, Zuccaro E, Genovese G, Loboda AA, Neumann A, Lilliehook C, Kuismin O, Hamalainen E, Kurki M, Hultman CM, Kähler AK, Paulo JA, Ganna A, Madison J, Cohen B, McPhie D, Adolfsson R, Perlis R, Dolmetsch R, Farhi S, McCarroll S, Hyman S, Neale B, Barrett LE, Harper W, Palotie A, Daly M, Eggan K. The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia. Nat Commun. 2022 Jun 27; 13: 3690.
  • Kolosov N, Daly MJ, Artomov M. Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning. Eur J Hum Genet. 2021 Oct; 29: 1527-1535.
  • Shchukina I, Bagaitkar J, Shpynov O, Loginicheva E, Porter S, Mogilenko DA, Wolin E, Collins P, Demidov G, Artomov M, Zaitsev K, Sidorov S, Camell C, Bambouskova M, Arthur L, Swain A, Panteleeva A, Dievskii A, Kurbatsky E, Tsurinov P, Chernyatchik R, Dixit VD, Jovanovic M, Stewart SA, Daly MJ, Dmitriev S, Oltz EM, Artyomov MN. Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome. Nat Aging. 2021 Jan; 1: 124-141.
  • Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An JY, Peng M, Collins R, Grove J, Klei L, Stevens C, Reichert J, Mulhern MS, Artomov M, Gerges S, Sheppard B, Xu X, Bhaduri A, Norman U, Brand H, Schwartz G, Nguyen R, Guerrero EE, Dias C, Autism Sequencing Consortium., iPSYCH-Broad Consortium., Betancur C, Cook EH, Gallagher L, Gill M, Sutcliffe JS, Thurm A, Zwick ME, Børglum AD, State MW, Cicek AE, Talkowski ME, Cutler DJ, Devlin B, Sanders SJ, Roeder K, Daly MJ, Buxbaum JD. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020 Feb 6; 180: 568-584.e23.
  • Shaughnessy M, Njauw CN, Artomov M, Tsao H. Classifying Melanoma by TERT Promoter Mutational Status. J Invest Dermatol. 2020 Feb; 140: 390-394.e1.
  • Heyne HO, Artomov M, Battke F, Bianchini C, Smith DR, Liebmann N, Tadigotla V, Stanley CM, Lal D, Rehm H, Lerche H, Daly MJ, Helbig I, Biskup S, Weber YG, Lemke JR. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med. 2019 Nov; 21: 2496-2503.
  • Artomov M, Stratigos AJ, Kim I, Kumar R, Lauss M, Reddy BY, Miao B, Daniela Robles-Espinoza C, Sankar A, Njauw CN, Shannon K, Gragoudas ES, Marie Lane A, Iyer V, Newton-Bishop JA, Timothy Bishop D, Holland EA, Mann GJ, Singh T, Daly MJ, Tsao H. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. J Natl Cancer Inst. 2017 Dec 1; 109:
  • Artomov M, Rivas MA, Genovese G, Daly MJ. Mosaic mutations in blood DNA sequence are associated with solid tumor cancers. NPJ Genom Med. 2017; 2: 22.

Education

Post Doctoral

Massachusetts General Hospital

Date Completed: 03/31/2021

Graduate School

Harvard University

Date Completed: 05/25/2017

Education

Post Doctoral

Massachusetts General Hospital

Date Completed: 03/31/2021

Graduate School

Harvard University

Date Completed: 05/25/2017

Education

Post Doctoral

Massachusetts General Hospital

Date Completed: 03/31/2021

Graduate School

Harvard University

Date Completed: 05/25/2017

Post Doctoral

Massachusetts General Hospital

Date Completed: 03/31/2021

Graduate School

Harvard University

Date Completed: 05/25/2017

Post Doctoral

Massachusetts General Hospital

Date Completed: 03/31/2021

Graduate School

Harvard University

Date Completed: 05/25/2017

Professional Experience

2012 - Present Broad Institute, Affiliated Researcher2021 - 2022 Massachusetts General Hospital, Instructor in Investigation2021 - 2022 Harvard Medical School, Instructor in Medicine

Professional Experience

2012 - Present Broad Institute, Affiliated Researcher2021 - 2022 Massachusetts General Hospital, Instructor in Investigation2021 - 2022 Harvard Medical School, Instructor in Medicine

Professional Experience

2012 - Present Broad Institute, Affiliated Researcher2021 - 2022 Massachusetts General Hospital, Instructor in Investigation2021 - 2022 Harvard Medical School, Instructor in Medicine

2012 - Present Broad Institute, Affiliated Researcher2021 - 2022 Massachusetts General Hospital, Instructor in Investigation2021 - 2022 Harvard Medical School, Instructor in Medicine

2012 - Present Broad Institute, Affiliated Researcher

Contact Information

Institute for Genomic Medicine

Call us at: (614) 722-6224

Email Mykyta Artomov

                    575 Children's CrossroadColumbus, OH 43215 (map)

Contact Information

Institute for Genomic Medicine

Call us at: (614) 722-6224

Email Mykyta Artomov

                    575 Children's CrossroadColumbus, OH 43215 (map)

Contact Information

Institute for Genomic Medicine

Call us at: (614) 722-6224

Email Mykyta Artomov

                    575 Children's CrossroadColumbus, OH 43215 (map)

Institute for Genomic Medicine

Call us at: (614) 722-6224

Email Mykyta Artomov

                    575 Children's CrossroadColumbus, OH 43215 (map)

Call us at: (614) 722-6224

Email Mykyta Artomov

                    575 Children's CrossroadColumbus, OH 43215 (map)

Call us at: (614) 722-6224

Email Mykyta Artomov

                    575 Children's CrossroadColumbus, OH 43215 (map)
  • Call us at:
  • (614) 722-6224
  • Email Mykyta Artomov
  • 575 Children’s CrossroadColumbus, OH 43215 (map)

Connect with Mykyta Artomov

Connect on ResearchGate